NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) —

Sotera Health Co. SHC

Lifshitz Law PLLC Announces an investigation into possible violations of securities laws and/or breaches of fiduciary duty related to allegations that the Company has made false and misleading representations regarding its emissions control systems and announces liability from lawsuits alleging the Company’s failure to recover harmful ETO – to limit emissions.

If you are a Sotera investor and would like additional information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Fate Therapeutics, Inc. FATE

Lifshitz Law PLLC announces an investigation into possible violations of securities laws and/or breaches of fiduciary duties related to allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Janssen Cooperation Agreement was less sustainable represented as Fate to investors; (ii) accordingly, certain clinical programs, milestone payments and royalties payments related to the Janssen Collaboration Agreement may not qualify as future revenue streams; (iii) as a result, Fate had overstated the impact of the Janssen Collaboration Agreement on Fate’s long-term clinical and commercial viability; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you are a Fate investor and would like additional information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Y-mAbs Therapeutics, Inc. YMAB

Lifshitz Law PLLC announces an investigation into possible violations of securities laws and/or breaches of fiduciary duty related to allegations that Y-mAbs misrepresented to investors that it was making progress related to the…